Cite
Impact of the addition of rituximab in overall survival in first line chemotherapy in follicular lymphoma: a population-based study from the Spanish Lymphoma Oncology Group (GOTEL)
MLA
L. de la Cruz Merino, et al. “Impact of the Addition of Rituximab in Overall Survival in First Line Chemotherapy in Follicular Lymphoma: A Population-Based Study from the Spanish Lymphoma Oncology Group (GOTEL).” Annals of Oncology, vol. 27, Oct. 2016, p. vi315. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........504f20e5676e5faaabf27842a34ad387&authtype=sso&custid=ns315887.
APA
L. de la Cruz Merino, Ana Blasco, Pilar Sabin, Maria Torrente, F.R. Garcia Arroyo, Marta Llanos, A. Rueda, J. Gomez Codina, Cristina Quero, & J. Guma I Padro. (2016). Impact of the addition of rituximab in overall survival in first line chemotherapy in follicular lymphoma: a population-based study from the Spanish Lymphoma Oncology Group (GOTEL). Annals of Oncology, 27, vi315.
Chicago
L. de la Cruz Merino, Ana Blasco, Pilar Sabin, Maria Torrente, F.R. Garcia Arroyo, Marta Llanos, A. Rueda, J. Gomez Codina, Cristina Quero, and J. Guma I Padro. 2016. “Impact of the Addition of Rituximab in Overall Survival in First Line Chemotherapy in Follicular Lymphoma: A Population-Based Study from the Spanish Lymphoma Oncology Group (GOTEL).” Annals of Oncology 27 (October): vi315. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........504f20e5676e5faaabf27842a34ad387&authtype=sso&custid=ns315887.